The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors
- Autores
- Teichmann, Tom; Pflüger Mülle, Beatrice; Martín Giménez, Virna Margarita; Sailer, Fiona; Dirks, Henrik; Zehr, Simonida; Warwick, Timothy; Brettner, Felix; Munoz Tello, Paola; Zimmer, Andreas; Tegeder, Irmgard; Thomas, Dominique; Gurke, Robert; Günther, Stefan; Heering, Jan; Proschak, Ewgenij; Geisslinger, Gerd; Bibli, Iris S.; Meyer zu Heringdorf, Dagmar; Manucha, Walter Ariel Fernando; Windbergs, Maike; Knapp, Stefan; Weigert, Andreas; Leisegang, Matthias S.; Kojetin, Douglas; Brandes, Ralf P.
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Endocannabinoids are lipid mediators, which elicit complex biological effects that extend beyond the central nervous system. The tissue concentrations of endocannabinoids increase in atherosclerosis, and for the endocannabinoid N-arachidonoyl-ethanolamine (anandamide; AEA), this has been linked to a potential anti-inflammatory function. Focusing on vascular smooth muscle cells, we set out to determine the underlying mechanism. Confirming previous results, AEA pretreatment attenuated the cytokine-mediated induction of inflammatory gene expression like CCL2. Unexpectedly, this effect was also observed in preparations of cannabinoid receptor (CB) 1 and 2 knockout mice and after pertussis toxin treatment but was restricted to fairly high concentrations of the lipid. The anti-inflammatory effect of AEA required preincubation, suggesting an effect through gene induction. RNA-seq revealed that AEA caused an increased expression of the nuclear receptors NR4A1 and NR4A2. Knockdown of these receptors blocked the AEA-mediated anti-inflammatory effect. Conversely, NR4A agonists (CsnB, C-DIM12) also attenuated inflammatory gene expression. Microscale thermophoresis, NMR-spectroscopy, and Gal4 reporter gene assays confirmed the binding of AEA to NR4A. Moreover, AEA caused an NR4A-dependent recruitment of the nuclear corepressor NCoR1 to the CCL2 promotor. Finally, AEA also elicited anti-inflammatory effects in the vascular organ culture of mice, which was not observed after the genetic deletion of NR4A1 or NR4A2.AEA elicits a specific anti-inflammatory response in vascular smooth muscle cells through activation of NR4A. AEA analogous with high potential to bind NR4A receptors might act as novel anti-inflammatory drugs.
Fil: Teichmann, Tom. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; Alemania
Fil: Pflüger Mülle, Beatrice. German Centre of Cardiovascular Research ; Alemania. Goethe Universitat Frankfurt; Alemania
Fil: Martín Giménez, Virna Margarita. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Catolica de Cuyo - Sede San Juan. Facultad de Ciencias de la Alimentación, Bioquímicas y Farmacéuticas. Instituto de Investigación en Ciencias Químicas; Argentina
Fil: Sailer, Fiona. Goethe Universitat Frankfurt; Alemania
Fil: Dirks, Henrik. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; Alemania
Fil: Zehr, Simonida. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; Alemania
Fil: Warwick, Timothy. German Centre of Cardiovascular Research ; Alemania. Goethe Universitat Frankfurt; Alemania
Fil: Brettner, Felix. Goethe Universitat Frankfurt; Alemania
Fil: Munoz Tello, Paola. Vanderbilt University; Estados Unidos
Fil: Zimmer, Andreas. Universitat Bonn; Alemania
Fil: Tegeder, Irmgard. Goethe Universitat Frankfurt; Alemania
Fil: Thomas, Dominique. Goethe Universitat Frankfurt; Alemania. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania
Fil: Gurke, Robert. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania. Goethe Universitat Frankfurt; Alemania
Fil: Günther, Stefan. Max Plank-Institute for Heart and Lung Research ; Alemania
Fil: Heering, Jan. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania
Fil: Proschak, Ewgenij. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania. Goethe Universitat Frankfurt; Alemania
Fil: Geisslinger, Gerd. Goethe Universitat Frankfurt; Alemania
Fil: Bibli, Iris S.. German Centre of Cardiovascular Research; Alemania. Goethe Universitat Frankfurt; Alemania
Fil: Meyer zu Heringdorf, Dagmar. University Hospital Frankfurt. Institute of General Pharmacology and Toxicology; Alemania. Goethe Universitat Frankfurt; Alemania
Fil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas; Argentina
Fil: Windbergs, Maike. Goethe Universitat Frankfurt; Alemania
Fil: Knapp, Stefan. Goethe Universitat Frankfurt; Alemania
Fil: Weigert, Andreas. Goethe Universitat Frankfurt; Alemania
Fil: Leisegang, Matthias S.. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research; Alemania
Fil: Kojetin, Douglas. Vanderbilt University; Estados Unidos
Fil: Brandes, Ralf P.. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research; Alemania - Materia
-
ANANDAMIDE
ANTIINFLAMMATORY EFFECTS
NR4A NUCLEAR RECEPTORS
ENDOCANNABINOIDS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/261401
Ver los metadatos del registro completo
id |
CONICETDig_0a6b4e997044cf6ac8beb5f854c23cc7 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/261401 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptorsTeichmann, TomPflüger Mülle, BeatriceMartín Giménez, Virna MargaritaSailer, FionaDirks, HenrikZehr, SimonidaWarwick, TimothyBrettner, FelixMunoz Tello, PaolaZimmer, AndreasTegeder, IrmgardThomas, DominiqueGurke, RobertGünther, StefanHeering, JanProschak, EwgenijGeisslinger, GerdBibli, Iris S.Meyer zu Heringdorf, DagmarManucha, Walter Ariel FernandoWindbergs, MaikeKnapp, StefanWeigert, AndreasLeisegang, Matthias S.Kojetin, DouglasBrandes, Ralf P.ANANDAMIDEANTIINFLAMMATORY EFFECTSNR4A NUCLEAR RECEPTORSENDOCANNABINOIDShttps://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3Endocannabinoids are lipid mediators, which elicit complex biological effects that extend beyond the central nervous system. The tissue concentrations of endocannabinoids increase in atherosclerosis, and for the endocannabinoid N-arachidonoyl-ethanolamine (anandamide; AEA), this has been linked to a potential anti-inflammatory function. Focusing on vascular smooth muscle cells, we set out to determine the underlying mechanism. Confirming previous results, AEA pretreatment attenuated the cytokine-mediated induction of inflammatory gene expression like CCL2. Unexpectedly, this effect was also observed in preparations of cannabinoid receptor (CB) 1 and 2 knockout mice and after pertussis toxin treatment but was restricted to fairly high concentrations of the lipid. The anti-inflammatory effect of AEA required preincubation, suggesting an effect through gene induction. RNA-seq revealed that AEA caused an increased expression of the nuclear receptors NR4A1 and NR4A2. Knockdown of these receptors blocked the AEA-mediated anti-inflammatory effect. Conversely, NR4A agonists (CsnB, C-DIM12) also attenuated inflammatory gene expression. Microscale thermophoresis, NMR-spectroscopy, and Gal4 reporter gene assays confirmed the binding of AEA to NR4A. Moreover, AEA caused an NR4A-dependent recruitment of the nuclear corepressor NCoR1 to the CCL2 promotor. Finally, AEA also elicited anti-inflammatory effects in the vascular organ culture of mice, which was not observed after the genetic deletion of NR4A1 or NR4A2.AEA elicits a specific anti-inflammatory response in vascular smooth muscle cells through activation of NR4A. AEA analogous with high potential to bind NR4A receptors might act as novel anti-inflammatory drugs.Fil: Teichmann, Tom. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; AlemaniaFil: Pflüger Mülle, Beatrice. German Centre of Cardiovascular Research ; Alemania. Goethe Universitat Frankfurt; AlemaniaFil: Martín Giménez, Virna Margarita. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Catolica de Cuyo - Sede San Juan. Facultad de Ciencias de la Alimentación, Bioquímicas y Farmacéuticas. Instituto de Investigación en Ciencias Químicas; ArgentinaFil: Sailer, Fiona. Goethe Universitat Frankfurt; AlemaniaFil: Dirks, Henrik. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; AlemaniaFil: Zehr, Simonida. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; AlemaniaFil: Warwick, Timothy. German Centre of Cardiovascular Research ; Alemania. Goethe Universitat Frankfurt; AlemaniaFil: Brettner, Felix. Goethe Universitat Frankfurt; AlemaniaFil: Munoz Tello, Paola. Vanderbilt University; Estados UnidosFil: Zimmer, Andreas. Universitat Bonn; AlemaniaFil: Tegeder, Irmgard. Goethe Universitat Frankfurt; AlemaniaFil: Thomas, Dominique. Goethe Universitat Frankfurt; Alemania. Fraunhofer Institute for Translational Medicine and Pharmacology; AlemaniaFil: Gurke, Robert. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania. Goethe Universitat Frankfurt; AlemaniaFil: Günther, Stefan. Max Plank-Institute for Heart and Lung Research ; AlemaniaFil: Heering, Jan. Fraunhofer Institute for Translational Medicine and Pharmacology; AlemaniaFil: Proschak, Ewgenij. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania. Goethe Universitat Frankfurt; AlemaniaFil: Geisslinger, Gerd. Goethe Universitat Frankfurt; AlemaniaFil: Bibli, Iris S.. German Centre of Cardiovascular Research; Alemania. Goethe Universitat Frankfurt; AlemaniaFil: Meyer zu Heringdorf, Dagmar. University Hospital Frankfurt. Institute of General Pharmacology and Toxicology; Alemania. Goethe Universitat Frankfurt; AlemaniaFil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas; ArgentinaFil: Windbergs, Maike. Goethe Universitat Frankfurt; AlemaniaFil: Knapp, Stefan. Goethe Universitat Frankfurt; AlemaniaFil: Weigert, Andreas. Goethe Universitat Frankfurt; AlemaniaFil: Leisegang, Matthias S.. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research; AlemaniaFil: Kojetin, Douglas. Vanderbilt University; Estados UnidosFil: Brandes, Ralf P.. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research; AlemaniaWiley Blackwell Publishing, Inc2024-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/261401Teichmann, Tom; Pflüger Mülle, Beatrice; Martín Giménez, Virna Margarita; Sailer, Fiona; Dirks, Henrik; et al.; The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors; Wiley Blackwell Publishing, Inc; British Journal of Pharmacology; 182; 5; 11-2024; 1164-11820007-1188CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.17366info:eu-repo/semantics/altIdentifier/doi/10.1111/bph.17366info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:06:54Zoai:ri.conicet.gov.ar:11336/261401instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:06:54.463CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors |
title |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors |
spellingShingle |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors Teichmann, Tom ANANDAMIDE ANTIINFLAMMATORY EFFECTS NR4A NUCLEAR RECEPTORS ENDOCANNABINOIDS |
title_short |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors |
title_full |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors |
title_fullStr |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors |
title_full_unstemmed |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors |
title_sort |
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors |
dc.creator.none.fl_str_mv |
Teichmann, Tom Pflüger Mülle, Beatrice Martín Giménez, Virna Margarita Sailer, Fiona Dirks, Henrik Zehr, Simonida Warwick, Timothy Brettner, Felix Munoz Tello, Paola Zimmer, Andreas Tegeder, Irmgard Thomas, Dominique Gurke, Robert Günther, Stefan Heering, Jan Proschak, Ewgenij Geisslinger, Gerd Bibli, Iris S. Meyer zu Heringdorf, Dagmar Manucha, Walter Ariel Fernando Windbergs, Maike Knapp, Stefan Weigert, Andreas Leisegang, Matthias S. Kojetin, Douglas Brandes, Ralf P. |
author |
Teichmann, Tom |
author_facet |
Teichmann, Tom Pflüger Mülle, Beatrice Martín Giménez, Virna Margarita Sailer, Fiona Dirks, Henrik Zehr, Simonida Warwick, Timothy Brettner, Felix Munoz Tello, Paola Zimmer, Andreas Tegeder, Irmgard Thomas, Dominique Gurke, Robert Günther, Stefan Heering, Jan Proschak, Ewgenij Geisslinger, Gerd Bibli, Iris S. Meyer zu Heringdorf, Dagmar Manucha, Walter Ariel Fernando Windbergs, Maike Knapp, Stefan Weigert, Andreas Leisegang, Matthias S. Kojetin, Douglas Brandes, Ralf P. |
author_role |
author |
author2 |
Pflüger Mülle, Beatrice Martín Giménez, Virna Margarita Sailer, Fiona Dirks, Henrik Zehr, Simonida Warwick, Timothy Brettner, Felix Munoz Tello, Paola Zimmer, Andreas Tegeder, Irmgard Thomas, Dominique Gurke, Robert Günther, Stefan Heering, Jan Proschak, Ewgenij Geisslinger, Gerd Bibli, Iris S. Meyer zu Heringdorf, Dagmar Manucha, Walter Ariel Fernando Windbergs, Maike Knapp, Stefan Weigert, Andreas Leisegang, Matthias S. Kojetin, Douglas Brandes, Ralf P. |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
ANANDAMIDE ANTIINFLAMMATORY EFFECTS NR4A NUCLEAR RECEPTORS ENDOCANNABINOIDS |
topic |
ANANDAMIDE ANTIINFLAMMATORY EFFECTS NR4A NUCLEAR RECEPTORS ENDOCANNABINOIDS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.4 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Endocannabinoids are lipid mediators, which elicit complex biological effects that extend beyond the central nervous system. The tissue concentrations of endocannabinoids increase in atherosclerosis, and for the endocannabinoid N-arachidonoyl-ethanolamine (anandamide; AEA), this has been linked to a potential anti-inflammatory function. Focusing on vascular smooth muscle cells, we set out to determine the underlying mechanism. Confirming previous results, AEA pretreatment attenuated the cytokine-mediated induction of inflammatory gene expression like CCL2. Unexpectedly, this effect was also observed in preparations of cannabinoid receptor (CB) 1 and 2 knockout mice and after pertussis toxin treatment but was restricted to fairly high concentrations of the lipid. The anti-inflammatory effect of AEA required preincubation, suggesting an effect through gene induction. RNA-seq revealed that AEA caused an increased expression of the nuclear receptors NR4A1 and NR4A2. Knockdown of these receptors blocked the AEA-mediated anti-inflammatory effect. Conversely, NR4A agonists (CsnB, C-DIM12) also attenuated inflammatory gene expression. Microscale thermophoresis, NMR-spectroscopy, and Gal4 reporter gene assays confirmed the binding of AEA to NR4A. Moreover, AEA caused an NR4A-dependent recruitment of the nuclear corepressor NCoR1 to the CCL2 promotor. Finally, AEA also elicited anti-inflammatory effects in the vascular organ culture of mice, which was not observed after the genetic deletion of NR4A1 or NR4A2.AEA elicits a specific anti-inflammatory response in vascular smooth muscle cells through activation of NR4A. AEA analogous with high potential to bind NR4A receptors might act as novel anti-inflammatory drugs. Fil: Teichmann, Tom. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; Alemania Fil: Pflüger Mülle, Beatrice. German Centre of Cardiovascular Research ; Alemania. Goethe Universitat Frankfurt; Alemania Fil: Martín Giménez, Virna Margarita. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Catolica de Cuyo - Sede San Juan. Facultad de Ciencias de la Alimentación, Bioquímicas y Farmacéuticas. Instituto de Investigación en Ciencias Químicas; Argentina Fil: Sailer, Fiona. Goethe Universitat Frankfurt; Alemania Fil: Dirks, Henrik. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; Alemania Fil: Zehr, Simonida. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research ; Alemania Fil: Warwick, Timothy. German Centre of Cardiovascular Research ; Alemania. Goethe Universitat Frankfurt; Alemania Fil: Brettner, Felix. Goethe Universitat Frankfurt; Alemania Fil: Munoz Tello, Paola. Vanderbilt University; Estados Unidos Fil: Zimmer, Andreas. Universitat Bonn; Alemania Fil: Tegeder, Irmgard. Goethe Universitat Frankfurt; Alemania Fil: Thomas, Dominique. Goethe Universitat Frankfurt; Alemania. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania Fil: Gurke, Robert. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania. Goethe Universitat Frankfurt; Alemania Fil: Günther, Stefan. Max Plank-Institute for Heart and Lung Research ; Alemania Fil: Heering, Jan. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania Fil: Proschak, Ewgenij. Fraunhofer Institute for Translational Medicine and Pharmacology; Alemania. Goethe Universitat Frankfurt; Alemania Fil: Geisslinger, Gerd. Goethe Universitat Frankfurt; Alemania Fil: Bibli, Iris S.. German Centre of Cardiovascular Research; Alemania. Goethe Universitat Frankfurt; Alemania Fil: Meyer zu Heringdorf, Dagmar. University Hospital Frankfurt. Institute of General Pharmacology and Toxicology; Alemania. Goethe Universitat Frankfurt; Alemania Fil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas; Argentina Fil: Windbergs, Maike. Goethe Universitat Frankfurt; Alemania Fil: Knapp, Stefan. Goethe Universitat Frankfurt; Alemania Fil: Weigert, Andreas. Goethe Universitat Frankfurt; Alemania Fil: Leisegang, Matthias S.. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research; Alemania Fil: Kojetin, Douglas. Vanderbilt University; Estados Unidos Fil: Brandes, Ralf P.. Goethe Universitat Frankfurt; Alemania. German Centre of Cardiovascular Research; Alemania |
description |
Endocannabinoids are lipid mediators, which elicit complex biological effects that extend beyond the central nervous system. The tissue concentrations of endocannabinoids increase in atherosclerosis, and for the endocannabinoid N-arachidonoyl-ethanolamine (anandamide; AEA), this has been linked to a potential anti-inflammatory function. Focusing on vascular smooth muscle cells, we set out to determine the underlying mechanism. Confirming previous results, AEA pretreatment attenuated the cytokine-mediated induction of inflammatory gene expression like CCL2. Unexpectedly, this effect was also observed in preparations of cannabinoid receptor (CB) 1 and 2 knockout mice and after pertussis toxin treatment but was restricted to fairly high concentrations of the lipid. The anti-inflammatory effect of AEA required preincubation, suggesting an effect through gene induction. RNA-seq revealed that AEA caused an increased expression of the nuclear receptors NR4A1 and NR4A2. Knockdown of these receptors blocked the AEA-mediated anti-inflammatory effect. Conversely, NR4A agonists (CsnB, C-DIM12) also attenuated inflammatory gene expression. Microscale thermophoresis, NMR-spectroscopy, and Gal4 reporter gene assays confirmed the binding of AEA to NR4A. Moreover, AEA caused an NR4A-dependent recruitment of the nuclear corepressor NCoR1 to the CCL2 promotor. Finally, AEA also elicited anti-inflammatory effects in the vascular organ culture of mice, which was not observed after the genetic deletion of NR4A1 or NR4A2.AEA elicits a specific anti-inflammatory response in vascular smooth muscle cells through activation of NR4A. AEA analogous with high potential to bind NR4A receptors might act as novel anti-inflammatory drugs. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/261401 Teichmann, Tom; Pflüger Mülle, Beatrice; Martín Giménez, Virna Margarita; Sailer, Fiona; Dirks, Henrik; et al.; The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors; Wiley Blackwell Publishing, Inc; British Journal of Pharmacology; 182; 5; 11-2024; 1164-1182 0007-1188 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/261401 |
identifier_str_mv |
Teichmann, Tom; Pflüger Mülle, Beatrice; Martín Giménez, Virna Margarita; Sailer, Fiona; Dirks, Henrik; et al.; The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors; Wiley Blackwell Publishing, Inc; British Journal of Pharmacology; 182; 5; 11-2024; 1164-1182 0007-1188 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.17366 info:eu-repo/semantics/altIdentifier/doi/10.1111/bph.17366 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269979508998144 |
score |
13.13397 |